IMPORTANT UPDATES

Back

Matthew L Paden, MD

Gender
Male
Language
English

Primary Specialty

Critical Care

Other Specialty

Pediatric Critical Care Medicine

Leadership Titles

Medical Director, Pediatrics ECMO and Advanced Technologies, Professor of Pediatrics

Education

Board Certification
Am Bd Pediatrics (Sub: Pediatric Critical Care Medicine), American Board of Pediatrics
Medical School:
University of Oklahoma at Tulsa College of Medicine
Residency:
Emory University School of Medicine
Fellowship:
Emory University School of Medicine

Publications

Pubmed Profile

Network

Children's Physician Group
The Children's Care Network

Introduction

Matt Paden, MD, is a Critical Care Medicine Physician at Children’s Healthcare of Atlanta and Professor of Pediatrics in the Division of Pediatric Critical Care Medicine at Emory University School of Medicine. He currently serves as Director of ECMO and Advanced Technologies at Children’s and is the past president and board member of the Extracorporeal Life Support Organization (ELSO).

Dr. Paden's clinical and research interests relate to the use of advanced technologies, including extracorporeal membrane oxygenation (ECMO), apheresis and continuous renal replacement therapies (CRRT) in critically ill children. His translational research focus includes KIDSCRRT, a NIH and FDA-funded novel device for CRRT in children, as well as the development of other pediatric medical devices.

Focus of Practice

  • Critical Care Medicine

Areas of Interest

  • ECMO

Locations

Childrens Physician Group - Critical Care

Egleston hospital, 1405 Clifton Rd NE 4th Floor Atlanta, GA 30322 Get Directions

Professional Affiliations

  • Extracorporeal Life Support Organization

Research & Publications

Dr. Paden's clinical and research interests relate to the use of advanced technologies, including extracorporeal membrane oxygenation (ECMO), apheresis and continuous renal replacement therapies (CRRT) in critically ill children. His translational research focus includes KIDSCRRT, a NIH and FDA-funded novel device for CRRT in children, as well as the development of other pediatric medical devices.